Product Details

Veronora is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Noradrenaline (as Noradrenaline Bitartrate BP) for intravenous use in the management of severe hypotension and shock. As a result, it offers a potent vasopressor for critical care and emergency settings.

The injection contains:

• Noradrenaline Bitartrate BP (as per specification) – A potent endogenous catecholamine that acts primarily on alpha-1 adrenergic receptors, with some beta-1 activity. Consequently, it produces strong vasoconstriction and increases systemic vascular resistance, raising blood pressure in states of severe hypotension.

Intensivists and emergency physicians use Veronora for the management of acute hypotension and shock, particularly septic shock, where restoring adequate perfusion pressure is critical. In addition, this concentrate must always be administered via continuous IV infusion under close haemodynamic monitoring, since rapid or undiluted administration carries significant risk. Because of this profile, Veronora suits ICUs and emergency departments equipped for continuous vasopressor infusion and monitoring.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the sterile formulation supports safe preparation for continuous IV infusion
• Furthermore, each vial delivers precise, validated dosage accuracy
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Critically, this product requires careful dilution and continuous monitoring during administration
• Ultimately, a reliable supply chain suits bulk distribution to hospitals and ICUs